Mar. 19, 2012

Interviews with leading Life Sciences companies: Interprotein, By Venture Valuation

Nov. 21, 2011

Ajinomoto Pharmaceuticals Co., Ltd. and Interprotein Corporation Sign a Joint R&D and Commercialization Agreement

Sep. 30, 2010

Interprotein and LegoChem Biosciences Sign Collaboration Agreement to Develop VEGF Inhibitor to Treat Solid Tumors

Sep. 27, 2010

Collaboration Agreement on Drug Discovery Research between Interprotein Corporation and Ajinomoto Pharmaceuticals Co., Ltd.

Nov. 25, 2009

Interviews with leading Life Sciences companies: Interprotein, By Venture Valuation

Nov. 21, 2008

Adoption of Interprotein’s VEGF project in Super Special Consortia for supporting the development of cutting-edge medical care

Feb. 27, 2007

Evotec and Interprotein Sign Collaboration Agreement to Develop Interleukin 6 Inhibitors to Treat Inflammatory Diseases

Jan. 27, 2006

Exclusive Patent Licensing of Degranulation Inhibiting Mechanism on Allergy-related Cells

Aug. 9, 2005

The announcement of Inter Cyto Nano Science and Dr. Jun Fujita, professor of the Kyoto University，agreed on a patent licensing of production yield improvement of recombinant protein